Compounds and methods for treating fibrotic pathologies

A compound of Formula (I):

• or a pharmaceutically acceptable salt thereof, wherein:
• R1 is selected from 5-6-membered heteroaryl ring comprising 1 to 5 heteroatoms selected from N, O, and S;
• wherein said heteroaryl ring is optionally substituted with 1, 2, or 3 substituents independently selected from R2;
• each R2 is independently selected from halo, OH, C1-3 alkoxy, SH, NH2, C1-3 alkylamino, di(C1-3 alkyl)amino, C1-3 alkyl, and C1-3 haloalkyl, wherein said C1-3 alkyl is optionally substituted with OH, C1-3 alkoxy, SH, NH2, C1-3 alkylamino, and di(C1-3 alkyl)amino;
• and
• R3 is selected from H and halo.